24 April 2009 - Actelion Ltd announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines, issued a positive opinion for the pediatric formulation of bosentan (Tracleer) for the treatment of pulmonary arterial hypertension (PAH).
the details can be read here.
No comments:
Post a Comment